Walleye Capital
GH icon

Walleye Capital’s Guardant Health GH Stock Holding History

Walleye Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Sell
4,600
-14,700
-76% -$1.48M ﹤0.01% 2788
2025
Q4 		$1.97M Sell
19,300
-17,300
-47% -$1.55M 0.01% 1887
2025
Q3 		$2.29M Buy
36,600
+24,300
+198% +$1.32M 0.01% 1464
2025
Q2 		$640K Buy
12,300
+10,600
+624% +$473K ﹤0.01% 2426
2025
Q1 		$72.4K Sell
1,700
-6,400
-79% -$276K ﹤0.01% 3736
2024
Q4 		$247K Sell
8,100
-12,100
-60% -$340K ﹤0.01% 3591
2024
Q3 		$463K Sell
20,200
-28,800
-59% -$815K ﹤0.01% 3364
2024
Q2 		$1.42M Buy
49,000
+44,100
+900% +$1.03M ﹤0.01% 2472
2024
Q1 		$101K Sell
4,900
-3,100
-39% -$66.5K ﹤0.01% 4391
2023
Q4 		$216K Sell
8,000
-3,800
-32% -$99.7K ﹤0.01% 3629
2023
Q3 		$350K Sell
11,800
-700
-6% -$24.6K ﹤0.01% 3105
2023
Q2 		$448K Buy
12,500
+4,300
+52% +$123K ﹤0.01% 2528
2023
Q1 		$192K Sell
8,200
-9,300
-53% -$266K ﹤0.01% 2503
2022
Q4 		$476K Buy
17,500
+16,100
+1,150% +$737K 0.01% 1487
2022
Q3 		$75K Buy
+1,400
New +$71.9K ﹤0.01% 2511
2020
Q1 		– Sell
-400
Closed -$31K – 1202
2019
Q4 		$31K Sell
400
-100
-20% -$7.21K ﹤0.01% 1564
2019
Q3 		$32K Sell
500
-500
-50% -$44K ﹤0.01% 1678
2019
Q2 		$86K Buy
+1,000
New +$76.4K 0.01% 1261

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's GH Position: Q1 2026 in Review

Walleye Capital increased its Guardant Health (GH) stake by 15% in Q1 2026, buying an estimated $3.78M and bringing the position to 291,926 shares worth $27M. The position accounts for 0.11% of the portfolio, ranked #118.

Walleye Capital first reported a position in GH in Q4 2019 and has held it in 18 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Walleye Capital held 291,926 shares of Guardant Health worth $27M as of Q1 2026.
  • Walleye Capital bought 37,624 Guardant Health shares in Q1 2026, an estimated $3.78M.
  • Guardant Health made up 0.11% of Walleye Capital's portfolio in Q1 2026, its #118 holding.
  • Walleye Capital first reported a position in Guardant Health in Q4 2019 and has held it in 18 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.